The underlying cause of late dumping syndrome is not completely understood, but in general, it is hypothesized that postoperative elevation of incretin hormone, especially GLP-1 levels, leads to pancreatic -cell hypertrophy (Figure 4)
Common gastrointestinal effects include: Bloating and gas : Increased fermentation activity from probiotic bacteria can produce excess intestinal gas, causing abdominal distension and discomfort Mild diarrhea or loose stools : Changes in gut flora composition may temporarily alter bowel habits Abdominal cramping : Some individuals experience mild to moderate cramping as their digestive system adapts Nausea : Less common but reported, particularly when supplements are taken on an empty stomach These symptoms are generally mild, self-limiting, and often resolve within days to weeks as the microbiome equilibrates
Stimulant-containing versions (like the caffeine in green tea extract) may cause jitteriness, a faster heartbeat, or trouble sleeping in people sensitive to caffeine, especially above the typical 400 mg daily threshold
Blue Cross Blue Shield of Michigan GLP-1 Coverage Changes Explained Understanding the New Coverage Changes As of August 1, 2024, Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN) are altering their coverage for GLP-1 receptor agonists, which include popular weight loss medications like Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)